Scheduled Programming of VNS Therapy Reduces Time-To-Dose and Office Visits in the COVID-19 Pandemic (P5-1.006)
Maxine Dibue, Roshani Patel, Michal Tzadok, Firas Fahoum, Charles Gordon, Riem El Tahry
Neurology Apr 2023, 100 (17 Supplement 2) 3974;
https://doi.org/10.1212/WNL.0000000000203652
Hot off the press - Scheduled programming is an optional feature available when using the latest VNS Therapy™ generator, SenTiva® (Livanova), that permits scheduled titration to the target dose to occur outside of the hospital environment (e.g. in the patient's home).
This recent study by Dibue et al. (Apr. 2023) examined the change in titration time and the number of office visits related to the use of the scheduled programming feature during the COVID-19 pandemic. The study is based on programming data collected primarily from North American centers in the year 2018 (pre-pandemic) and the year 2020 (Mar. to Dec., peri-pandemic). Important findings include:
➤ An increased frequency in the use of scheduled programming during the pandemic, from 23.5% in 2018 (pre-pandemic) to 30.5% in 2020 (peri-pandemic).
➤ The use of scheduled programming features increased the number of total titration steps from 3.5 to 3.8 during the pandemic.
➤ A slight reduction in the number of office visits was observed between the pre-pandemic (-1.9 visits) and the peri-pandemic (−2.1 visits) period.
Noteworthy, due to the data included in the current study being collected from certain geographical areas, the outcome may vary based on the restriction rules in specific regions during the pandemic. Despite this, the findings proved that scheduled programming can be a helpful tool for VNS dosing and titration when remote patient management is needed.
For additional information regarding scheduled programming, the SenTiva® generator, and our company, check out these websites:
SenTiva®: https://lnkd.in/eZati3Zw
Go North Medical: https://lnkd.in/eUKuEfbM
Link to the article: https://lnkd.in/eH8KEj2A
